Simply Wall St
4 min read
As global markets navigate a period of volatility, with tech stocks facing pressure and value-oriented segments gaining traction, Asia’s stock markets are also experiencing fluctuations influenced by economic data and geopolitical factors. In this environment, identifying undervalued stocks requires careful analysis of companies that may benefit from shifting investor preferences towards sectors less exposed to recent market disruptions.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Zhaojin Mining Industry (SEHK:1818) |
HK$32.44 |
HK$64.09 |
49.4% |
|
Ningxia Building Materials GroupLtd (SHSE:600449) |
CN¥13.62 |
CN¥26.70 |
49% |
|
Helens International Holdings (SEHK:9869) |
HK$0.91 |
HK$1.77 |
48.7% |
|
HD Renewable Energy (TWSE:6873) |
NT$108.00 |
NT$213.27 |
49.4% |
|
Fuji Media Holdings (TSE:4676) |
¥3560.00 |
¥7042.73 |
49.5% |
|
EROAD (NZSE:ERD) |
NZ$0.97 |
NZ$1.88 |
48.4% |
|
DIGITAL HEARTS HOLDINGS (TSE:3676) |
¥878.00 |
¥1727.05 |
49.2% |
|
CURVES HOLDINGS (TSE:7085) |
¥764.00 |
¥1527.45 |
50% |
|
Auntea Jenny (Shanghai) Industrial (SEHK:2589) |
HK$85.80 |
HK$169.87 |
49.5% |
|
Asia-potash International Investment (Guangzhou)Co.Ltd (SZSE:000893) |
CN¥56.59 |
CN¥109.88 |
48.5% |
Let’s dive into some prime choices out of the screener.
Overview: Hugel, Inc. is a company that develops and manufactures biopharmaceuticals both in South Korea and internationally, with a market capitalization of ₩2.85 trillion.
Operations: The company’s revenue segments include the development and manufacturing of biopharmaceuticals for both domestic and international markets.
Estimated Discount To Fair Value: 33.4%
Hugel, Inc. is trading at a 33.4% discount to its estimated fair value and significantly below future cash flow value, suggesting it may be undervalued based on cash flows. The company reported KRW 425.1 billion in sales and KRW 138 billion in net income for 2025, with earnings expected to grow over 20% annually for the next three years. Hugel’s strategic expansion into the U.S., including a hybrid sales model, aims to enhance profitability and market share.
-
Our growth report here indicates Hugel may be poised for an improving outlook.
-
Click here to discover the nuances of Hugel with our detailed financial health report.
Overview: APR Co., Ltd. manufactures and sells cosmetic products for men and women, with a market cap of ₩10.56 billion.
Operations: The company’s revenue segments include ₩1.54 billion from cosmetics and ₩38.63 million from the clothing fashion sector, with important adjustments of -₩358.74 million.
